Anders Molven

12.3k citations

195 papers · 10.1k · 2 hit papers · h-index 58

Impact in

Genetics top 0.5%
- Diabetes and associated disorders
- Genetic Associations and Epidemiology
- Genomics and Rare Diseases
Oncology top 2%
- Cutaneous Melanoma Detection and Management
- Cancer Cells and Metastasis

Papers in

Genetics 52
- Diabetes and associated disorders 27
- Genetic Associations and Epidemiology 19
- Genomics and Rare Diseases 8
Surgery 69
- Pancreatic function and diabetes 52
- Pancreatitis Pathology and Treatment 26

Co-authors: Pål R. Njølstad (94 shared papers)Oddmund Sövik (25 shared papers)Helge Ræder (29 shared papers)Heike Immervoll (15 shared papers)Stefan Johansson (31 shared papers)Dag Hoem (16 shared papers)Lise Bjørkhaug (15 shared papers)Anders Fjose (11 shared papers)
Journals: Diabetes (15 papers)Pancreatology (14 papers)Nature Genetics (8 papers)Diabetologia (6 papers)PLoS ONE (5 papers)
Partner nations: Norway United States United Kingdom

In The Last Decade

Anders Molven

192 papers receiving 9.8k citations

Anders Molven's Hit Papers

align trajectories log scale

A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer 2016 · 380 citations

What are hit papers?

Paper score: A paper's citations measured against the top-1% bar of its own field and year: the square root of citations ÷ bar, so 1 means right at the bar and 2 means four times its citations. The bar blends the citation counts that enter the top 1% of the paper's subfields in its year (weighted 89.5%), of those subfields over all years (0.5%) and of its year across all fields (10%); a subfield and year with fewer than 400 papers takes its year's bar. Papers from 2026 are not scored yet: in an unfinished year, when a paper appeared matters more than how it is cited.

Hit paper: A paper cited at least 1.5× the top-1% bar of its field and year: a paper score of at least √1.5.

2016 Journal of Controlled Release
2014 Nature Genetics

Peers

Countries citing papers authored by Anders Molven

Since Specialization

Citations

This map shows the geographic impact of Anders Molven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Molven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Molven more than expected).

Fields of papers citing papers by Anders Molven

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Molven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Molven. The network helps show where Anders Molven may publish in the future.

Co-authors

The 25 scholars most cited alongside Anders Molven, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anders Molven Line = papers co-authored together Anders Molven links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 195 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells International Journal of Cancer ·Jian Wang, Per Øystein Sakariassen, Oleg Tsinkalovsky, Heike Immervoll, Stig Ove Bøe, Agnete S. T. Engelsen, Lars Prestegarden, Gro Vatne Røsland	2007	464
2	Loss-of-function mutations in SLC30A8 protect against type 2 diabetes Nature Genetics ·Jason A. Flannick, Guðmar Þorleifsson, Nicola L. Beer, Suzanne B.R. Jacobs, Niels Grarup, Noël P. Burtt, Anubha Mahajan, Christian Fuchsberger Hit paper breakdown →	2014	409
3	A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer Journal of Controlled Release ·Georg Gjorgji Dimcevski, Spiros Kotopoulis, Tormod Karlsen Bjånes, Dag Hoem, Jan Didrik Schjøtt, Bjørn Tore Gjertsen, Martin Biermann, Anders Molven Hit paper breakdown →	2016	380
4	Neonatal Diabetes Mellitus Due to Complete Glucokinase Deficiency New England Journal of Medicine ·Pål R. Njølstad, Oddmund Sövik, Antonio Luis Cuesta-Muñoz, Lise Bjørkhaug, Ornella Massa, Fabrizio Barbetti, Dag Erik Undlien, Chiyo Shiota	2001	344
5	Permanent Neonatal Diabetes due to Mutations in KCNJ11 Encoding Kir6.2 Diabetes ·Jørn Vegard Sagen, Helge Ræder, Eba H. Hathout, Naim Shehadeh, Kolbeinn Gudmundsson, Halvor Bævre, Dianne N. Abuelo, Chanika Phornphutkul	2004	281
6	Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction Nature Genetics ·Helge Ræder, Stefan Johansson, Pål I. Holm, Ingfrid S. Haldorsen, Eric Mas, Véronique Sbarra, Ingrid Nermoen, Stig Å Eide	2005	276
7	Spontaneous Malignant Transformation of Human Mesenchymal Stem Cells Reflects Cross-Contamination: Putting the Research Field on Track – Letter Cancer Research ·Anja Torsvik, Gro Vatne Røsland, Agnete S. T. Engelsen, Anders Molven, Heike Immervoll, Emmet McCormack, Per Eystein Lønning, Monika Primon	2010	252
8	Genome-wide association study identifies three new melanoma susceptibility loci Nature Genetics ·Jennifer H. Barrett, Mark Martin Iles, Mark Harland, John Taylor, Joanne F. Aitken, Per Arne Andresen, Lars A. Akslen, Bruce Konrad Armstrong	2011	210
9	Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma Nature Genetics ·Matthew H. Law, David Timothy Bishop, Jeffrey E. Lee, Myriam Brossard, Nicholas G. Martin, Eric Keith Moses, Fengju Song, Jennifer H. Barrett	2015	194
10	Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas BMC Cancer ·Heike Immervoll, Dag Hoem, Per Øystein Sakariassen, Ole Johnny Steffensen, Anders Molven	2008	186
11	Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX , SOX4 , and IRX3 Proceedings of the National Academy of Sciences ·Anja Ragvin, Enrico Moro, David Fredman, Pavla Navrátilová, Øyvind Drivenes, Pär G. Engström, Elisa de la Calle‐Mustienes, José Luis Gómez-Skármeta	2009	176
12	Familial Hyperinsulinemic Hypoglycemia Caused by a Defect in the SCHAD Enzyme of Mitochondrial Fatty Acid Oxidation Diabetes ·Anders Molven, Guri E. Matre, Marinus Durán, Ronald Wanders, Unni Rishaug, Pål R. Njølstad, Egil Jellum, Oddmund Sövik	2004	173
13	Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 gene FEBS Letters ·Roger Løvlie, Ann K. Daly, Anders Molven, Jeffrey R. Idle, Vidar M. Steen	1996	172
14	Mutations in the Insulin Gene Can Cause MODY and Autoantibody-Negative Type 1 Diabetes Diabetes ·Anders Molven, Monika Ringdal, Anita M. Nordbø, Helge Ræder, Julie Støy, Gregory M. Lipkind, Donald F. Steiner, Louis H. Philipson	2008	170
15	Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility Nature Genetics ·Maria Teresa Landi, David Timothy Bishop, Stuart MacGregor, Mitchell J. Machiela, Alexander Stratigos, Paola Ghiorzo, Myriam Brossard, Donato Calista	2020	164
16	Disruption of a long distance regulatory region upstream of SOX9 in isolated disorders of sex development Journal of Medical Genetics ·Sabina Benko, Christopher T. Gordon, Rajini Sreenivasan, Christel Thauvin‐Robinet, Atle Brendehaug, Sophie Thomas, Ove Bruland, Michel David	2011	160
17	Permanent Neonatal Diabetes Caused by Glucokinase Deficiency Diabetes ·Pål R. Njølstad, Jørn Vegard Sagen, Lise Bjørkhaug, Stella Odili, Naim Shehadeh, Doua Bakry, S. Ümit Sarící, Faruk Alpay	2003	149
18	A recombined allele of the lipase gene CEL and its pseudogene CELP confers susceptibility to chronic pancreatitis Nature Genetics ·Karianne Fjeld, Frank Ulrich Weiß, Denise Lasher, Jonas Rosendahl, Jian‐Min Chen, Bente Berg Johansson, Holger Kirsten, Claudia Ruffert	2015	148
19	U‐251 revisited: genetic drift and phenotypic consequences of long‐term cultures of glioblastoma cells Cancer Medicine ·Anja Torsvik, Daniel Stieber, Per Øyvind Enger, Anna Golebiewska, Anders Molven, Agnete S. T. Engelsen, Bengt Westermark, Simone P. Niclou	2014	142
20	Molecular analysis of the PI3K‐AKT pathway in uterine cervical neoplasia: Frequent PIK3CA amplification and AKT phosphorylation International Journal of Cancer ·Bjørn Inge Bertelsen, Solrun Johanne Steine, Roar Sandvei, Anders Molven, Ole Didrik Lærum	2005	137

About Anders Molven

Anders Molven is a scholar working on Genetics, Surgery, Oncology, Molecular Biology and Pharmacology, having authored 195 papers that have together received 10.1k indexed citations. Recurring topics across this work include Pancreatic function and diabetes (52 papers), Diabetes and associated disorders (27 papers), Pancreatitis Pathology and Treatment (26 papers), Genetic Associations and Epidemiology (19 papers), Developmental Biology and Gene Regulation (13 papers), Pancreatic and Hepatic Oncology Research (13 papers), Cutaneous Melanoma Detection and Management (13 papers) and Genomics and Rare Diseases (8 papers). The work is most often cited by research in Genetics (3.1k citations), Oncology (1.6k citations), Genetics (578 citations), Surgery (2.8k citations) and Pharmacology (372 citations). Anders Molven has collaborated with scholars based in Norway, United States and United Kingdom. Frequent co-authors include Pål R. Njølstad, Oddmund Sövik, Helge Ræder, Heike Immervoll, Stefan Johansson, Dag Hoem, Lise Bjørkhaug, Anders Fjose, Jørn Vegard Sagen and Ingfrid S. Haldorsen. Their work appears in journals such as Diabetes, Pancreatology, Nature Genetics, Diabetologia and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Anders Molven

Impact in

Papers in i

In The Last Decade

Anders Molven

Anders Molven's Hit Papers

Peers

Countries citing papers authored by Anders Molven

Fields of papers citing papers by Anders Molven

All Works

About Anders Molven

Explore authors with similar magnitude of impact

Papers in